Gene therapy in lung transplantation.

Area of Science:

• Regenerative Medicine
• Transplantation Immunology
• Molecular Therapy

Background:

• Lung transplantation is a vital treatment for end-stage lung diseases but faces significant hurdles.
• Organ donor scarcity, early graft failure, and chronic dysfunction limit its application.
• These complications stem from pre- and post-transplant lung injuries, including ischemia-reperfusion and immune responses.

Purpose of the Study:

• To explore the potential of gene therapy as a molecular solution for lung transplantation.
• To address the challenges of lung injury and graft dysfunction.
• To review the current state and future directions of gene therapy in lung transplantation.

Main Methods:

• Review of existing research and the authors' work on gene therapy for lung transplantation.
• Discussion of key considerations for gene delivery strategies.
• Analysis of factors influencing gene expression and therapeutic outcomes.

Main Results:

• Lung transplantation presents unique advantages for gene therapy due to predictable injuries and the lung's anatomy.
• Immunosuppressive regimens can enhance and prolong gene expression.
• Various administration routes, timing strategies, and vector/gene selections are crucial.

Conclusions:

• Gene therapy holds significant promise for improving outcomes in lung transplantation.
• Further research into optimized gene delivery strategies is essential.
• This approach could mitigate lung injury and enhance graft survival, addressing critical limitations in current transplantation practices.